Infertility study: Automated Vitrification vs Manual Vitrification
Official title Automation of Oocyte and Embryo Vitrification
ClinicalTrials.gov ID: NCT07197983
What this study is testing
- What it's testing
- The study wants to find out if an automated system can preserve eggs and embryos just as effectively as the current manual method used by experts.
- Who it's for
- People undergoing fertility treatment at CARE Fertility Manchester who have extra eggs or embryos that are not being used for their own treatment.
- What's involved
- Participants will have their unused eggs and embryos split into two groups: one frozen by hand and one frozen by the new machine. Both groups will be thawed later to check how many survive.
- Time commitment
- The study involves no extra visits or tests for the patient, as it only uses materials that would otherwise be discarded.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 38
You may be able to join if
- BMI: Between 20-35 kg/m²
- Ovarian Reserve: Anti-Müllerian Hormone (AMH) ≥1.5 ng/mL
You likely can't join if
- Low ovarian reserve
- Surgical sperm retrieval required
The study team makes the final eligibility decision.
Where it is enrolling
- Manchester, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 38 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Manchester, United Kingdom. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.